International Journal of Obstetric Anesthesia
Volume 15, Issue 2 , Pages 163-165 , April 2006

Anesthetic management for cesarean delivery in a woman with Gilles de la Tourette’s syndrome

  • E.B. Sener

      Affiliations

    • Corresponding Author InformationCorrespondence to: Elif Bengi Sener MD, Assistant Professor in Anesthesia, Ondokuz Mayis University, Faculty of Medicine, Department of Anesthesiology, Kurupelit 55139, Samsun, Turkey. Tel.: +90 362 3121919/3350/4576000; fax: +90 362 4576041.
    • ,
  • S. Kocamanoglu
    • ,
  • E. Ustun
    • ,
  • A. Tur

,Accepted 1 July 2005.

References 

  1. Singer HS. Tourette’s syndrome: from behaviour to biology. Review. Lancet Neurol. 2005;4:149–159
  2. Yoshikawa F, Takagi T, Fukayama H, Miwa Z, Umino M. Intravenous sedation and general anesthesia for a patient with Gilles de la Tourette’s syndrome undergoing dental treatment. Acta Anaesthesiol Scand. 2002;46:1279–1280
  3. Morrison JE, Lockhart CH. Tourette syndrome: Anesthetic implications. Anesth Analg. 1986;65:200–202
  4. Bordet R. Central dopaminergic receptors (Part II): pathophysiological and therapeutic considerations. Rev Neurol. 2004;160:986–992
  5. Jimenez-Jimenez FJ, Garcia-Ruiz PJ. Pharmacological options for the treatment of Tourette’s disorder. Drugs. 2001;61:2207–2220
  6. Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette’s syndrome. Am J Psychiatry. 1978;135:585–587
  7. Shapiro AK, Shapiro E, Eisenkraft GJ. Treatment of Tourette disorder with penfluridol. Compr Psychiatry. 1983;24:327–331
  8. Muller-Vahl KR. The treatment of Tourette’s syndrome: current opinions. Expert Opin Pharmacother. 2002;3:899–914
  9. Smith MS, Evatt ML. Movement disorders in pregnancy. Neurol Clin. 2004;22:783–798
  10. Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D. Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology. 1980;71:219–225
  11. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;15–19:379–390
  12. Acosta MT, Castellanos FX. Use of the “inverse neuroleptic” metoclopramide in Tourette syndrome: an open case series. J Child Adolesc Psychopharmacol. 2004;14:123–128
  13. Ye HC, Xie XL, You Y. Effects of metoclopramide on intelligence and memory in patients with Tourette syndrome. Hunan Yi Ke Da Xue Xue Bao. 2003;28:301–303
  14. Ye JH, Ponnudurai R, Schaefer R, Knecht T. Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001;7:199–213
  15. Sandyk R, Awerbuch G. Recurrence of complex motor and vocal tics in an elderly woman responsive to opiates. Int J Neurosci. 1989;44:317–320
  16. Kessler AR. Clonidine treatment increases tics in patients with Tourette syndrome: case report. J Child Neurol. 2001;16:380–381

PII: S0959-289X(05)00141-X

doi: 10.1016/j.ijoa.2005.07.004

International Journal of Obstetric Anesthesia
Volume 15, Issue 2 , Pages 163-165 , April 2006

Article Tools